Unraveling adenosine and AMP induced dyspnea sensation in asthma
C. Cox (Groningen, Netherlands), I. Boudewijn (Groningen, Netherlands), S. Vroegop (Groningen, Netherlands), S. Schokker (Groningen, Netherlands), A. Lexmond (Groningen, Netherlands), H. Frijlink (Groningen, Netherlands), P. Hagedoorn (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), M. Farenhorst (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)
Source: International Congress 2018 – Tests and trends in asthma
Session: Tests and trends in asthma
Session type: Thematic Poster
Number: 3961
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Cox (Groningen, Netherlands), I. Boudewijn (Groningen, Netherlands), S. Vroegop (Groningen, Netherlands), S. Schokker (Groningen, Netherlands), A. Lexmond (Groningen, Netherlands), H. Frijlink (Groningen, Netherlands), P. Hagedoorn (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), M. Farenhorst (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands). Unraveling adenosine and AMP induced dyspnea sensation in asthma. 3961
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Tussive challenge with ATP and AMP: does it reveal cough hypersensitivity? Source: Eur Respir J , 49 (2) 1601452; DOI: 10.1183/13993003.01452-2016 Year: 2017
Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006
The adenosine A2A -Receptor is not involved in adenosine induced bronchoconstriction in asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003
The perception of breathlessness during bronchoconstriction induced by mannitol in COPD Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008
Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Cellular and gas exchange responses to adenosine 5‘-monophosphate (AMP) challenge in mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Source: Eur Respir J 2001; 17: 64-70 Year: 2001
Blunted sensation of dyspnoea and near fatal asthma Source: Eur Respir J 2004; 24: 197-199 Year: 2004
Characterization of methacholine-induced cough and its influence on cough reflex sensitivity and airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 591s Year: 2005
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Source: Eur Respir J 2002; 19: 611-616 Year: 2002
Changes in the pattern of breathing and dyspnoea sensation during methacholine-induced bronchoconstriction in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 86s Year: 2001
Peculiarities of dyspnea sensations in asthma patients Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010
Chronic cough: ATP, afferent pathways and hypersensitivity Source: Eur Respir J, 54 (1) 1900889; 10.1183/13993003.00889-2019 Year: 2019
Effect of adenosine 5´-triphosphate (ATP) challenge vs. adenosine 5´-monophosphate (AMP) on the threshold of capsaicin-induced cough in healthy non-smokers, current smokers and patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 708s Year: 2004
Association between atopic status and airway reactivity to methacholine and adenosine monophosphate Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
ATP and cough reflex hypersensitivity: a confusion of goals? Source: Eur Respir J, 50 (1) 1700802; 10.1183/13993003.00802-2017 Year: 2017
ATP and cough reflex hypersensitivity: a confusion of goals? Source: Eur Respir J, 50 (1) 1700579; 10.1183/13993003.00579-2017 Year: 2017
An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) Source: International Congress 2017 – Monitoring asthma control Year: 2017
The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004